Background: Complement factor H antibody (CFH-Ab) associated hemolytic uremic syndrome (HUS) is different from the genetically defined aHUS forms, especially concerning diagnosis and treatment.
Case: We report a case of aHUS responsive to plasmapheresis with a slightly delayed detection of CFHAb after first disease recurrence. The initiation of immunosuppressive induction and maintenance therapy led to a sustained complete remission.
Conclusion: This case of CFH-Ab HUS responsive to PP and remission after initiation of IS supports the recently published guidelines on therapy of CFH-Ab aHUS and highlights the importance of a fast diagnosis of this rare disease entity.
Johannes Hofer, Hannah-Sophie Arbeiter, Mihály Józsi, Thomas Giner, Diana Dobiliene, Jurate Masalskiene, Jonas Surkus and Sarunas Rudaitis
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : July 15, 2019